Condition
Congenital Heart Block
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 2 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT00074373Completed
The Research Registry for Neonatal Lupus
NCT01379573Phase 2CompletedPrimary
Preventive Approach to Congenital Heart Block With Hydroxychloroquine
NCT00460928Early Phase 1CompletedPrimary
Preventive IVIG Therapy for Congenital Heart Block
NCT00007358Not ApplicableCompletedPrimary
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
Showing all 4 trials